Evidence Under Fire: New Debate Over How Medication Optimisation Tools Should Be Judged
A letter in European Geriatric Medicine argues that disputes over the STOPP/START criteria expose the need for transparent evidence-grading standards ...
A letter in European Geriatric Medicine argues that disputes over the STOPP/START criteria expose the need for transparent evidence-grading standards ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
A nationwide Finnish register study of 282,307 adults examines how sociodemographic and socioeconomic factors shape who uses anti-obesity medications.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine